Dandan Huang

A specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors

Y. Li, Wen-long Huang, Hai Qian, 2012, Journal of Molecular Modeling.

Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2.

Wen-long Huang, Hai Qian, W. Shi, 2018, European journal of medicinal chemistry.

Design, Synthesis and Biological Evaluation of 5-Amino-1H-pyrazole-4- carboxamide Derivatives as Potential Antitumor Agents

Wen-long Huang, Hai Qian, R. Gust, 2014 .

Discovery, Synthesis and Evaluation of Novel Cholesterol Absorption Inhibitors

Wen-long Huang, Hai Qian, Xiao-yun Zhu, 2012, Chemical biology & drug design.

Corrigendum to 'Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2' [European journal of medicinal chemistry 158 (2018) 814-831].

Wen-long Huang, Hai Qian, W. Shi, 2019, European journal of medicinal chemistry.

Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.

Wen-long Huang, Hai Qian, Xiao-yun Zhu, 2013, Journal of medicinal chemistry.

Design, synthesis and biological evaluation of 4-aminopyrimidine-5-cabaldehyde oximes as dual inhibitors of c-Met and VEGFR-2.

Wen-long Huang, Hai Qian, W. Shi, 2016, Bioorganic & medicinal chemistry.

The first pharmacophore model for potent G protein-coupled receptor 119 agonist.

Wen-long Huang, Hai Qian, Xiao-yun Zhu, 2011, European journal of medicinal chemistry.

3D QSAR pharmacophore modeling for c-Met kinase inhibitors.

Wen-long Huang, Hai Qian, Xiao-yun Zhu, 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).